MetLife (MET)
(Delayed Data from NYSE)
$81.79 USD
+0.01 (0.01%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $81.78 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$81.79 USD
+0.01 (0.01%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $81.78 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth C Momentum B VGM
Zacks News
Are Investors Undervaluing MetLife (MET) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
MetLife (MET) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
MetLife (MET) Q1 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Metlife (MET) earnings gain from an increase in revenues, partly offset by rise in expenses.
MetLife (MET) Surpasses Q1 Earnings Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of 13.85% and -0.33%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Why MetLife (MET) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
The Zacks Analyst Blog Highlights: Visa, Boeing, Coca-Cola, MetLife and O'Reilly
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Visa, Boeing, Coca-Cola, MetLife and O'Reilly
MetLife (MET) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Revenue growth, cost-savings efforts to aid MetLife's (MET) earnings in Q1, which will be partly offset by lower investment income.
Top Research Reports for Visa, Boeing & Coca-Cola
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Visa (V), Boeing (BA) and Coca-Cola (KO).
Earnings Preview: MetLife (MET) Q1 Earnings Expected to Decline
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are You Looking for a High-Growth Dividend Stock? MetLife (MET) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
Will MetLife (MET) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
MetLife (MET) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why MetLife (MET) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
Aflac's (AFL) Japan Business to Drive Long-Term Growth
by Zacks Equity Research
Changes in Japan's economy and aging population is likely to drive growth at Aflac (AFL).
Why MetLife (MET) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
Why Is MetLife (MET) Up 1.8% Since Last Earnings Report?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Top Research Reports for McDonald's, CVS Health & Celgene
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including McDonald's (MCD), CVS Health (CVS) and Celgene (CELG).
CNO Financial's (CNO) Q4 Earnings Lag Estimates, Fall Y/Y
by Zacks Equity Research
CNO Financial's (CNO) fourth-quarter earnings fall shy of estimates due to lower revenues.
Q4 Earnings Drive Insurance ETFs Higher
by Sweta Killa
The Q4 earnings of insurance industry players had a positive impact on the related ETFs that saw smooth trading over the past month.
Why MetLife (MET) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
MetLife (MET) Q4 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
MetLife's (MET) Q4 earnings gain from a decline in total expenses and revenues remain flat year over year.
Insurers' Q4 Earnings Roster for Feb 6: MET, PRU, CINF, LNC
by Zacks Equity Research
Insurers are likely to benefit from interest rate hikes, improved pricing, continued share repurchases, though cat loss will weigh on underwriting profitability.
Factors Likely to Shape MetLife (MET) This Earnings Season
by Zacks Equity Research
MetLife (MET) fourth-quarter 2018 earnings should gain from increase in revenues and accretion from share buyback program, partly offset by catastrophe losses.
MetLife (MET) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MGIC Investment (MTG) Q4 Earnings Beat, Revenues Up Y/Y
by Zacks Equity Research
MGIC Investment (MTG) Q4 results reflect lower credit losses, improved net premiums earned, and impact of lower tax and share buybacks.
Are Investors Undervaluing MetLife (MET) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.